Search
IO Biotech Inc
IOBTAdd to Watchlist
0.048USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
366.94KMarket Cap
LossP/E TTM
More Details of IO Biotech Inc Company
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
IO Biotech Inc Info
Ticker SymbolIOBT
Company nameIO Biotech Inc
IPO dateNov 05, 2021
CEOZocca (Mai-Britt)
Number of employees80
Security typeOrdinary Share
Fiscal year-endNov 05
AddressOle Maaloes Veh 3
CityCOPENHAGEN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryDenmark
Postal code2200
Phone4570702980
Websitehttps://www.iobiotech.com/
Ticker SymbolIOBT
IPO dateNov 05, 2021
CEOZocca (Mai-Britt)
Company Executives of IO Biotech Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+70.87%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Dr. Peter Hirth, Ph.D.
Dr. Peter Hirth, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Christian E. Elling, Ph.D.
Dr. Christian E. Elling, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
Mr. David V. Smith
Mr. David V. Smith
Independent Director
Independent Director
--
--
Mr. Brian Burkavage
Mr. Brian Burkavage
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
--
--
Ms. Amy B. Sullivan
Ms. Amy B. Sullivan
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
--
--
Dr. Qasim Ahmad, M.D.
Dr. Qasim Ahmad, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+70.87%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Dr. Peter Hirth, Ph.D.
Dr. Peter Hirth, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Christian E. Elling, Ph.D.
Dr. Christian E. Elling, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of IO Biotech Inc?
The top five shareholders of IO Biotech Inc are: Dr. Mai-Britt Zocca, Ph.D.
How many institutions hold shares of IO Biotech Inc (IOBT)?
As of 2026Q1, 56 institutions hold shares of IO Biotech Inc, with a combined market value of approximately 33.96M, accounting for 47.71% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -19145442.00.